leisure time -WSS

leisure time

author：entertainment 2025-09-03 15:20:12 - browse：68

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Stanford updates investigation of president’s past research

WSS

STAT Summit: How researchers deal with rejection

DOJ, FTC to increase scrutiny of all types of health care mergers

Results on Novartis prostate cancer therapy could expand its use

Why a market frenzy over new weight loss drugs defies logic

J&J lung cancer data amount to new salvo against AstraZeneca

Why a market frenzy over new weight loss drugs defies logic

focus

leisure time

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT Summit: How researchers deal with rejection

United colonoscopy coverage change 'may cost lives,' doctors say

Stanford president to resign after investigation of research

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Is there really a nursing shortage in the U.S.?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Stanford updates investigation of president’s past research

At least 13 dead in Texas as scorching temps continue

STAT Summit: How researchers deal with rejection

knowledge

Stanford president to resign after investigation of research

J&J lung cancer data amount to new salvo against AstraZeneca

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Smaller biotechs seek to piggyback on weight loss drug boom

Why a market frenzy over new weight loss drugs defies logic

Resistance to cancer drugs: A new genetic explanation

focus

entertainment

hotspot

hotspot